Half year 2022 results
29/09/2022
RNS
Notice of Results and Investor Presentation
15/09/2022
Liquidity Agreement and Total Voting Rights
01/09/2022
Launch of first fully lyophilised PROmate® assays
04/08/2022
01/08/2022
Launch of research-use-only adenovirus F41 assay
28/07/2022
Results of AGM
20/07/2022
Director/PDMR Shareholding
15/07/2022
Approval of exsig™ COVID-19 Direct test in the UK
07/07/2022
Trading update and progress against strategy
Holdings in Company
05/07/2022
01/07/2022
Launch of monkeypox assay
28/06/2022
Notice of rescheduled AGM
21/06/2022
DHSC dispute update
16/06/2022
AGM Voting
13/06/2022
01/06/2022
Publication of Annual Report and AGM voting
CTDA approval and CE mark
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
